Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24859930
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Arch+Toxicol
2014 ; 88
(6
): 1249-56
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Mitochondrial dysregulation and protection in cisplatin nephrotoxicity
#MMPMID24859930
Yang Y
; Liu H
; Liu F
; Dong Z
Arch Toxicol
2014[Jun]; 88
(6
): 1249-56
PMID24859930
show ga
Nephrotoxicity is a major side effect of cisplatin in chemotherapy.
Pathologically, cisplatin nephrotoxicity is characterized by cell injury and
death in renal tubules. The research in the past decade has gained significant
understanding of the cellular and molecular mechanisms of tubular cell death,
revealing a central role of mitochondrial dysregulation. The pathological changes
in mitochondria in cisplatin nephrotoxicity are mainly triggered by DNA damage
response, pro-apoptotic protein attack, disruption of mitochondrial dynamics, and
oxidative stress. As such, inhibitory strategies targeting these cytotoxic events
may provide renal protection. Nonetheless, ideal approaches for renoprotection
should not only protect kidneys but also enhance the anticancer efficacy of
cisplatin in chemotherapy.
|Animals
[MESH]
|Antineoplastic Agents/adverse effects
[MESH]
|Apoptosis/drug effects
[MESH]
|Cisplatin/*adverse effects
[MESH]
|DNA Damage/drug effects
[MESH]
|Humans
[MESH]
|Kidney Diseases/*chemically induced/physiopathology/prevention & control
[MESH]